Sage Therapeutics
SAGE
#6817
Rank
โ‚ฌ0.42 B
Marketcap
6,85ย โ‚ฌ
Share price
0.00%
Change (1 day)
-45.86%
Change (1 year)

EPS for Sage Therapeutics (SAGE)

EPS in 2023 (TTM): -9,37ย โ‚ฌ

According to Sage Therapeutics 's latest financial reports the company's current EPS (TTM) is -8,73ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -7,90ย โ‚ฌ a decrease over its 2021 EPS that were of -6,86ย โ‚ฌ.

EPS history for Sage Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-9,37ย โ‚ฌ18.68%
2022-7,90ย โ‚ฌ15.13%
2021-6,86ย โ‚ฌ-167.18%
202010,21ย โ‚ฌ-186.77%
2019-11,77ย โ‚ฌ66.21%
2018-7,08ย โ‚ฌ13.06%
2017-6,26ย โ‚ฌ51.49%
2016-4,13ย โ‚ฌ38.64%
2015-2,98ย โ‚ฌ104.43%
2014-1,46ย โ‚ฌ52.1%
2013-0,96ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,49ย โ‚ฌ-82.96%๐Ÿ‡บ๐Ÿ‡ธ USA
0,81ย โ‚ฌ-109.27%๐Ÿ‡บ๐Ÿ‡ธ USA
1,69ย โ‚ฌ-119.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
5,62ย โ‚ฌ-164.42%๐Ÿ‡บ๐Ÿ‡ธ USA